PL2233153T3 - Szczepionka rotawirusowa wywołująca heterotypową ochronę krzyżową - Google Patents

Szczepionka rotawirusowa wywołująca heterotypową ochronę krzyżową

Info

Publication number
PL2233153T3
PL2233153T3 PL10159949T PL10159949T PL2233153T3 PL 2233153 T3 PL2233153 T3 PL 2233153T3 PL 10159949 T PL10159949 T PL 10159949T PL 10159949 T PL10159949 T PL 10159949T PL 2233153 T3 PL2233153 T3 PL 2233153T3
Authority
PL
Poland
Prior art keywords
cross protection
rotavirus vaccine
vaccine inducing
heterotypic cross
heterotypic
Prior art date
Application number
PL10159949T
Other languages
English (en)
Inventor
Brigitte Desiree Alberte Colau
Vos Beatrice Arsene Virginie De
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0516944A external-priority patent/GB0516944D0/en
Priority claimed from GB0521164A external-priority patent/GB0521164D0/en
Priority claimed from GB0608962A external-priority patent/GB0608962D0/en
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of PL2233153T3 publication Critical patent/PL2233153T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL10159949T 2005-08-17 2006-08-15 Szczepionka rotawirusowa wywołująca heterotypową ochronę krzyżową PL2233153T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0516944A GB0516944D0 (en) 2005-08-17 2005-08-17 Vaccine
GB0521164A GB0521164D0 (en) 2005-10-18 2005-10-18 Vaccine
GB0608962A GB0608962D0 (en) 2006-05-05 2006-05-05 Vaccine
EP06776899A EP1915173A2 (en) 2005-08-17 2006-08-15 Rotavirus vaccine inducing heterotypic cross protection
EP10159949.6A EP2233153B1 (en) 2005-08-17 2006-08-15 Rotavirus vaccine inducing heterotypic cross protection

Publications (1)

Publication Number Publication Date
PL2233153T3 true PL2233153T3 (pl) 2015-06-30

Family

ID=37757924

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10159949T PL2233153T3 (pl) 2005-08-17 2006-08-15 Szczepionka rotawirusowa wywołująca heterotypową ochronę krzyżową

Country Status (25)

Country Link
US (1) US20090028828A1 (pl)
EP (2) EP1915173A2 (pl)
JP (1) JP5519934B2 (pl)
KR (1) KR20080036648A (pl)
AR (1) AR054916A1 (pl)
AU (1) AU2006281566B2 (pl)
BR (1) BRPI0615203A2 (pl)
CA (1) CA2619751C (pl)
CR (1) CR9759A (pl)
CY (1) CY1116135T1 (pl)
DK (1) DK2233153T3 (pl)
EA (1) EA014328B1 (pl)
ES (1) ES2534637T3 (pl)
HR (1) HRP20150310T1 (pl)
IL (1) IL189289A0 (pl)
MA (1) MA29700B1 (pl)
MX (1) MX2008002270A (pl)
NO (1) NO20080754L (pl)
PE (1) PE20070235A1 (pl)
PL (1) PL2233153T3 (pl)
PT (1) PT2233153E (pl)
SG (1) SG163571A1 (pl)
SI (1) SI2233153T1 (pl)
TW (1) TW200740457A (pl)
WO (1) WO2007020078A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107510D0 (en) 2001-03-26 2001-05-16 Univ Bristol New elongase gene and a process for the production of -9-polyunsaturated fatty acids
WO2009042202A2 (en) 2007-09-25 2009-04-02 Aridis Pharmaceuticals Formulations for preservation of rota virus
US9311112B2 (en) * 2009-03-16 2016-04-12 Apple Inc. Event recognition
BR112013027457A2 (pt) * 2011-04-28 2019-09-24 Int Medica Foundation preparação de vacina, e, métodos de fabricar uma preparação de vacina, e de vacinar um mamífero
CN110227152A (zh) * 2012-04-23 2019-09-13 巴拉特生物技术国际有限公司 轮状病毒疫苗组合物及其制备方法
EP3359651A1 (en) 2015-10-05 2018-08-15 THE UNITED STATES OF AMERICA, represented by the S Human rota virus g9p[6]strain and use as a vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0171434B1 (ko) * 1990-11-16 1999-02-01 윌리엄 케이. 슈버트 인체 로타바이러스, 백신 및 방법
TR200200420T2 (tr) * 1999-08-17 2002-05-21 Smithkline Beecham Biologicals S.A. Aşı
WO2005021033A2 (en) * 2003-09-02 2005-03-10 Glaxosmithkline Biologicals S.A. Vaccine

Also Published As

Publication number Publication date
WO2007020078A2 (en) 2007-02-22
EA014328B1 (ru) 2010-10-29
AU2006281566B2 (en) 2011-09-01
DK2233153T3 (da) 2015-04-27
AU2006281566A1 (en) 2007-02-22
CA2619751C (en) 2016-07-05
EP2233153A1 (en) 2010-09-29
CA2619751A1 (en) 2007-02-22
JP2009504701A (ja) 2009-02-05
EP2233153B1 (en) 2015-01-21
NO20080754L (no) 2008-05-15
IL189289A0 (en) 2008-06-05
EP1915173A2 (en) 2008-04-30
KR20080036648A (ko) 2008-04-28
SG163571A1 (en) 2010-08-30
CY1116135T1 (el) 2017-02-08
BRPI0615203A2 (pt) 2011-05-10
EA200800320A1 (ru) 2008-10-30
PE20070235A1 (es) 2007-04-04
HRP20150310T1 (hr) 2015-06-19
CR9759A (es) 2008-05-05
WO2007020078A3 (en) 2007-05-24
SI2233153T1 (sl) 2015-05-29
ES2534637T3 (es) 2015-04-27
TW200740457A (en) 2007-11-01
JP5519934B2 (ja) 2014-06-11
MA29700B1 (fr) 2008-08-01
MX2008002270A (es) 2008-03-27
PT2233153E (pt) 2015-04-20
AR054916A1 (es) 2007-07-25
US20090028828A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
IL192084A0 (en) Vaccine
GB0504436D0 (en) Vaccine
ZA200804918B (en) Therapeutic vaccine
ZA200708634B (en) Novel vaccine formulations
IL186828A0 (en) Vaccine composition
IL187769A0 (en) Anti-malaria vaccine
IL189289A0 (en) Rotavirus vaccine inducing heterotypic cross protection
ZA200801405B (en) Rotavirus vaccine inducing heterotypic cross protection
GB0524409D0 (en) Vaccines
GB2439242B (en) Protection sleeve
ZA200709207B (en) Vaccine
GB0810662D0 (en) Vaccine
GB0515135D0 (en) Vaccine
GB0524408D0 (en) Vaccines
ZA200709210B (en) Vaccine
HK1118223A (en) Rotavirus vaccine inducing heterotypic cross protection
GB0511203D0 (en) Vaccines
GB0526412D0 (en) Vaccine
GB0513194D0 (en) Vaccine
GB0514021D0 (en) Vaccine
GB0503000D0 (en) Anti-atheroma vaccine
IL186586A0 (en) Vaccine
GB0526232D0 (en) Vaccine
GB0523445D0 (en) Vaccine
IL186591A0 (en) Vaccine